Rezolute Inc. (NV) (RZLT)

Name: Rezolute Inc. (NV) (RZLT) Share Price Today, Stock Analysis, Annual Report | Value Research
Brand: Rezolute Inc. (NV) (RZLT)

Stock Card

$4.62

$-0.36 (-7.23%)

As on 28-Aug-2026 16:00EDT

Market cap

$445 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

P/B Ratio

4.1

Div. Yield

0 %

Rezolute Inc. (NV) (RZLT) Share Price

Compare

High: Low: Return:

Price P/E Ratio P/B Ratio

Stock Range

Today’s Range

Low: 4.58 High: 4.95

52 Week Range

Low: 1.07 High: 11.46

Liquidity

Low Moderate High

Fundamentals

Net Profit (TTM)

$0 Mln
ROE

-0.8 %
ROCE

-- %
Industry P/E

--
EV/EBITDA

-0
Debt to Equity

0
Book Value

$1.1
EPS

$-0.8
Face value

--
Shares outstanding

96,292,331

10 Years Aggregate

CFO

$-192.17 Mln

EBITDA

$-235.62 Mln

Net Profit

$-248.76 Mln

Company	YTD	1 Month	3 Months	1 Year	3 Years	5 Years	10 Years
Rezolute Inc. (NV) (RZLT)	95.8	-6.5	39.2	-35.8	47.8	-12.8	-20.1
BSE Sensex^*	-9.1	-1.2	2.9	-3.6	5.7	6.2	10.5
S&P Small-Cap 600^#	-5.8	-5.3	-13.7	-6.3	5.3	3.0	5.5

As on 28-Aug-2026 | *As on 31-Aug-2026 | #As on 26-Oct-2023

Company	2025	2024	2023	2022	2021	2020	2019
Rezolute Inc. (NV) (RZLT)	-51.8	387.1	-52.0	-56.7	-60.1	108.5	27.8
S&P Small-Cap 600	4.0	7.0	13.9	-17.4	25.3	9.6	20.9
BSE Sensex	9.1	8.1	18.7	4.4	22.0	15.8	14.4

Essential Checks

View Details

Is there a threat to the company's solvency?

Can creative accounting be detected through the financial numbers?

How did the company perform in the last one year?

Financials

View Details

Key Ratios

View Details

Peers

View Details

Company	Price ($)	Market Cap ($ Mln)	Revenue (TTM)	Net Profit (TTM)	OPM (%)	ROE (%)	P/E	P/B
Rezolute Inc. (NV) (RZLT)	4.6	444.9	0.1	-81.5	-177,141.3	-61.7	--	4.1
Arrowhead Pharmaceuticals (ARWR)	84.9	11,993.9	669.5	-320.0	-0.8	-71.1	--	26.9
Ascendis Pharma A/S - ADR	247.9	16,261.1	1,054.4	755.9	5.7	--	19	9.8
Cytokinetics Inc (CYTK)	72.1	10,022.2	71.0	-894.0	-1,175.8	--	--	60.3
Exelixis (EXEL)	54.5	13,491.7	2,435.9	860.6	31.0	43	17.4	7.4
Halozyme Therapeutics (HALO)	105.4	11,957.0	1,663.7	413.6	36.3	430	30.9	84.5
Krystal Biotech (KRYS)	351.5	10,402.8	440.5	241.5	33.4	18.7	44.1	7.8
Madrigal Pharmaceuticals (MDGL)	533.8	12,332.1	1,283.9	-325.1	-19.0	-57.7	--	24.0
Medpace Holdings (MEDP)	600.7	16,765.1	2,782.3	491.5	21.1	110.1	35.2	39.3
Praxis Precision MedicinesÂ Inc (PRAX)	344.8	9,625.4	0.0	-339.1	--	-30.6	--	7.6

Shareholding Pattern

View Details

About Rezolute Inc. (NV) (RZLT)

Rezolute, Inc., a late-stage rare disease company, focused on improving outcomes for individuals with hypoglycemia caused by hyperinsulinism in the United States. Its lead clinical asset is ersodetug, an intravenously administered human monoclonal... antibody that is in Phase 3 clinical trial for the treatment of congenital hyperinsulinism, an ultra-rare pediatric genetic disorder, as well as for the treatment of hypoglycemia; and clinical trials of ersodetug for tumor hyperinsulinism. The company was formerly known as AntriaBio, Inc. and changed its name to Rezolute, Inc. in December 2017. Rezolute, Inc. was founded in 2010 and is headquartered in Redwood City, California. Read more

Founder, CEO & Acting Chairman of the Board

Mr. Nevan Charles Elam J.D.
Founder, CEO & Acting Chairman of the Board

Mr. Nevan Charles Elam J.D.
Headquarters

Redwood City, CA
Website

https://www.rezolutebio.com

FAQs for Rezolute Inc. (NV) (RZLT)

What is the current share price of Rezolute Inc (NV) (RZLT) Today?

The share price of Rezolute Inc (NV) (RZLT) is $4.62 (NASDAQ) as of 28-Aug-2026 16:00 EDT. Rezolute Inc (NV) (RZLT) has given a return of 47.83% in the last 3 years.

What is the current PB & PE ratio of Rezolute Inc (NV) (RZLT)?

Since, TTM earnings of Rezolute Inc (NV) (RZLT) is negative, P/E ratio is not available.
The P/B ratio of Rezolute Inc (NV) (RZLT) is 4.09 times as on 28-Aug-2026, a 21 discount to its peers’ median range of 5.18 times.

PE & PB ratio at the end of financial year.

Year	P/E Ratio	P/B Ratio
2025	-5.65	2.60
2024	-3.19	1.81
2023	-1.97	0.88
2022	-1.53	0.42
2021	-5.70	4.57

What is the 52 Week High and Low of Rezolute Inc (NV) (RZLT)?

The 52-week high and low of Rezolute Inc (NV) (RZLT) are Rs 11.46 and Rs 1.07 as of 31-Aug-2026.

What is the market cap of Rezolute Inc (NV) (RZLT)?

Rezolute Inc (NV) (RZLT) has a market capitalisation of $ 445 Mln as on 28-Aug-2026. As per SEBI classification, it is a Small Cap company.

Should I invest in Rezolute Inc (NV) (RZLT)?

Before investing in Rezolute Inc (NV) (RZLT), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.

For guidance, explore our expert-curated portfolios and Stock recommendations with Value Research Stock Advisor.

Want to explore on your own? Click here to see how this stock scores on quality, growth, valuation, and momentum.